Theodore R. Schroeder - Jan 29, 2022 Form 4 Insider Report for Nabriva Therapeutics plc (NBRV)

Role
Chief Executive Officer, Director
Signature
/s/ J. Christopher Naftzger, by power of attorney
Stock symbol
NBRV
Transactions as of
Jan 29, 2022
Transactions value $
-$4,905
Form type
4
Date filed
2/1/2022, 07:47 PM
Previous filing
Feb 1, 2022
Next filing
Feb 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBRV Ordinary Shares Tax liability -$4.84K -10.8K -3.31% $0.45 315K Jan 29, 2022 Direct F1
transaction NBRV Ordinary Shares Tax liability -$60 -125 -0.04% $0.48 315K Jan 31, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.